1,000
Participants
Start Date
December 31, 2002
Primary Completion Date
March 31, 2004
Study Completion Date
March 31, 2004
Telmisartan 80 mg + hydrochlorothiazide 12.5 mg
Amlodipine 10 mg + hydrochlorothiazide 12.5 mg
Boehringer Ingelheim Investigational Site, Dublin
Cardioperfect Research Room, Dublin
Beaumont Park Clinic, Dublin
19 Redwood View, Dublin
Adelaide and Meath Hospitals (incorrporating NCH), Dublin
A.Z. VUB, Brussels
A.C.Z. Antwerpen/Stuyvenberg, Antwerp
C.H.U. Liège (Ourthe-Amblève), Esneux
Boehringer Ingelheim Investigational Site, Aywaille
Boehringer Ingelheim Investigational Site, Odder
Hospital Gral de Jerez de la Frontera, Jerez de La Frontera / Cádiz
Boehringer Ingelheim Investigational Site, Berlin
Boehringer Ingelheim Investigational Site, Berlin
Hôpital de la Timone, Marseille
Avda. Menendez Pidal, s&n, Córdoba
Boehringer Ingelheim Investigational Site, Hatten
"Azienda Ospedaliera Maggiore della Carità", Novara
Ospedale Civile, Vittorio Veneto (TV)
Cardiology Service, Santander
Università di Ferrara, Ferrara
Boehringer Ingelheim Investigational Site, Marl
Boehringer Ingelheim Investigational Site, Münster
Boehringer Ingelheim Investigational Site, Westerkappeln
Boehringer Ingelheim Investigational Site, Mayenne
Boehringer Ingelheim Investigational Site, Château Gontier Bazougues
Boehringer Ingelheim Investigational Site, Jarny
Boehringer Ingelheim Investigational Site, Hagen
Evangelisches Krankenhaus, Witten
Boehringer Ingelheim Investigational Site, Werne
Boehringer Ingelheim Investigational Site, Rodgau-Dudenhofen
Deutsche Klinik für Diagnostik GmbH, Wiesbaden
Boehringer Ingelheim Investigational Site, Flörsheim
Boehringer Ingelheim Investigational Site, Kelkheim
Boehringer Ingelheim Investigational Site, Esslingen am Neckar
Ospedale Scillesi d'America, Scilla (rc)
Boehringer Ingelheim Investigational Site, Nuremberg
Boehringer Ingelheim Investigational Site, Rednitzhembach
Boehringer Ingelheim Investigational Site, Ornbau
Boehringer Ingelheim Investigational Site, Straßkirchen
Boehringer Ingelheim Investigational Site, Wallerfing
Ospedale S. Luigi - S. Currò, Catania
Boehringer Ingelheim Investigational Site, Aabenraa
Boehringer Ingelheim Investigational Site, Christiansfeld
Boehringer Ingelheim Investigational Site, Haderslev
Boehringer Ingelheim Investigational Site, Herning
Boehringer Ingelheim Investigational Site, Hvidovre
Boehringer Ingelheim Investigational Site, Rødovre Municipality
Boehringer Ingelheim Investigational Site, Vildberg
Boehringer Ingelheim Investigational Site, Vildbjerg
Boehringer Ingelheim Investigational Site, Vinderup
Hämeenlinnan lääkäriasema Oy, Linnan klinikka, Hämeenlinna
Diacor, Helsinki
Kiljava Medical Research, Hyvinkää
Boehringer Ingelheim Investigational Site, Jyväskylä
Kouvolan lääkäriasema, Kouvola
Hatanpään terveyskeskussairaala, Tampere
Boehringer Ingelheim Investigational Site, Angers
Boehringer Ingelheim Investigational Site, Aÿ
Boehringer Ingelheim Investigational Site, Kilkenny
"Az. Osped. Universitaria Osp. Riuniti", Foggia
Boehringer Ingelheim Investigational Site, Musselkanaal
Boehringer Ingelheim Investigational Site, Vaals
Boehringer Ingelheim Investigational Site, Voerendaal
Boehringer Ingelheim Investigational Site, Ellefeld
Boehringer Ingelheim Investigational Site, Leipzig
Boehringer Ingelheim Investigational Site, Riesa
Boehringer Ingelheim Investigational Site, Beek en Donk
Boehringer Ingelheim Investigational Site, Ewijk
Boehringer Ingelheim Investigational Site, Oude Pekela
Boehringer Ingelheim Investigational Site, Rijswijk
Boehringer Ingelheim Investigational Site, Roelofarendsveen
Boehringer Ingelheim Investigational Site, The Hague
Boehringer Ingelheim Investigational Site, Pretoria
Lead Sponsor
Boehringer Ingelheim
INDUSTRY